Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2011 (2011), Article ID 196518, 8 pages
http://dx.doi.org/10.4061/2011/196518
Review Article

Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension

1Veterans Affairs and Georgetown University Medical Centers, 50 Irving Street, Washington, DC 20422, USA
2Aristotle University of Thessaloniki, Thessaloniki, Greece
3National and Kapodistrian University of Athens, Athens, Greece

Received 1 October 2010; Revised 22 December 2010; Accepted 19 January 2011

Academic Editor: Alan Gradman

Copyright © 2011 Vasilios Papademetriou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Calhoun, D. Jones, S. Textor et al., “Resistant hypertension: siagnosis, evaluation, and treatment a scientific statement from the american heart association professional education committee of the council for high blood pressure research,” Hypertension, vol. 51, no. 6, pp. 1403–1419, 2008. View at Publisher · View at Google Scholar · View at PubMed
  2. P. A. Sarafidis and G. L. Bakris, “Resistant hypertension. An overview of evaluation and treatment,” Journal of the American College of Cardiology, vol. 52, no. 22, pp. 1749–1757, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. Moser and J. F. Setaro, “Resistant or difficult-to-control hypertension,” The New England Journal of Medicine, vol. 355, no. 4, pp. 385–392, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. D. Wojciechowski, V. Papademetriou, C. Faselis, and R. Fletcher, “Evaluation and treatment of resistant or difficult-to-control hypertension,” Journal of Clinical Hypertension, vol. 10, no. 11, pp. 837–843, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. Veterans Administration Cooperative Study Group on Antihypertensive Agents, “Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg,” Journal of the American Medical Association, vol. 202, no. 11, pp. 1028–1034, 1967. View at Google Scholar
  6. Veterans Administration Cooperative Study Group on Antihypertensive Agents, “Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg,” Journal of the American Medical Association, vol. 202, pp. 1143–1152, 1970. View at Google Scholar
  7. I. H. Page and G. J. Heuer, “A surgical treatment of essential hypertension,” The Journal of Clinical Investigation, vol. 14, pp. 22–26, 1935. View at Google Scholar
  8. R. H. Freyberg and M. M. Peet, “The effect on the kidney of bilateral splanchnicectomy in patients with hypertension,” The Journal of Clinical Investigation, vol. 16, pp. 49–65, 1937. View at Google Scholar
  9. R. H. Smithwick, “Surgical treatment of hypertension,” The American Journal of Medicine, vol. 4, no. 5, pp. 744–759, 1948. View at Google Scholar · View at Scopus
  10. E. M. Isberg and M. M. Peet, “The influence of supradiaphragmatic splanchnicectomy on the heart in hypertension,” American Heart Journal, vol. 35, no. 4, pp. 567–583, 1948. View at Google Scholar · View at Scopus
  11. E. V. Allen, “Sympathectomy for essential hypertension,” Circulation, vol. 6, no. 1, pp. 131–140, 1952. View at Google Scholar · View at Scopus
  12. G. P. Whitelaw, D. Kinsey, and R. H. Smithwick, “Factors influencing the choice of treatment in essential hypertension. Surgical, medical or a combination of both,” The American Journal of Surgery, vol. 107, no. 1, pp. 220–231, 1964. View at Google Scholar · View at Scopus
  13. M. Doumas, D. Guo, and V. Papademetriou, “Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions,” Expert Opinion on Therapeutic Targets, vol. 13, no. 4, pp. 413–425, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. H. Krum, M. Schlaich, R. Whitbourn et al., “Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study,” The Lancet, vol. 373, no. 9671, pp. 1275–1281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Doumas and S. Douma, “Interventional management of resistant hypertension,” The Lancet, vol. 373, no. 9671, pp. 1228–1230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. G. F. DiBona and U. C. Kopp, “Neural control of renal function,” Physiological Reviews, vol. 77, no. 1, pp. 75–197, 1997. View at Google Scholar · View at Scopus
  17. U. C. Kopp and G. F. DiBona, “The neural control of renal function,” in The Kidney: Physiology and Pathophysiology, G. Seldin and G. Giebisch, Eds., pp. 981–1006, Raven Press, New York, NY, USA, 3rd edition, 2006. View at Google Scholar
  18. L. Barajas, L. Liu, and K. Powers, “Anatomy of the renal innervation: intrarenal aspects and ganglia of origin,” Canadian Journal of Physiology and Pharmacology, vol. 70, no. 5, pp. 735–749, 1992. View at Google Scholar · View at Scopus
  19. S. E. Luff, S. G. Hengstberger, E. M. McLachlan, and W. P. Anderson, “Distribution of sympathetic neuroeffector junctions in the juxtaglomerular region of the rabbit kidney,” Journal of the Autonomic Nervous System, vol. 40, no. 3, pp. 239–254, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Barajas, K. Powers, and P. Wang, “Innervation of the renal cortical tubules: a quantitative study.,” American Journal of Physiology, vol. 247, no. 1, pp. F50–F60, 1984. View at Google Scholar · View at Scopus
  21. M. Esler, “The sympathetic system and hypertension,” American Journal of Hypertension, vol. 13, no. 6, pp. S99–S105, 2000. View at Google Scholar · View at Scopus
  22. M. Esler, M. Rumantir, D. Kaye et al., “Sympathetic nerve biology in essential hypertension,” Clinical and Experimental Pharmacology and Physiology, vol. 28, no. 12, pp. 986–989, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. U. C. Kopp, M. Z. Cicha, K. Nakamura, R. M. Nüsing, L. A. Smith, and T. Hökfelt, “Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves,” American Journal of Physiology, vol. 287, no. 6, pp. F1269–F1282, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. U. C. Kopp, M. Z. Cicha, L. A. Smith, and T. Hökfelt, “Nitric oxide modulates renal sensory nerve fibers by mechanisms related to substance preceptor activation,” American Journal of Physiology, vol. 281, no. 1, pp. R279–R290, 2001. View at Google Scholar · View at Scopus
  25. L. Liu and L. Barajas, “The rat renal nerves during development,” Anatomy and Embryology, vol. 188, no. 4, pp. 345–361, 1993. View at Google Scholar · View at Scopus
  26. A. Stella and A. Zanchetti, “Functional role of renal afferents,” Physiological Reviews, vol. 71, no. 3, pp. 659–682, 1991. View at Google Scholar · View at Scopus
  27. N. M. Keith, H. P. Wagener, and N. W. Barker, “Some different types of essential hypertension: their course and prognosis,” American Journal of the Medical Sciences, vol. 268, no. 6, pp. 336–345, 1974. View at Google Scholar · View at Scopus
  28. R. H. Smithwick, “Hypertensive vascular disease. Results of and indications for splanchnicectomy,” Journal of Chronic Diseases, vol. 1, no. 5, pp. 477–496, 1955. View at Google Scholar · View at Scopus
  29. M. P. Schlaich, P. A. Sobotka, H. Krum, E. Lambert, and M. D. Esler, “Renal sympathetic-nerve ablation for uncontrolled hypertension,” The New England Journal of Medicine, vol. 361, no. 9, pp. 932–934, 2009. View at Publisher · View at Google Scholar · View at PubMed
  30. M. D. Esler, H. Krum, P. A. Sobotka et al., “Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial,” The Lancet, vol. 376, no. 9756, pp. 1903–1909, 2010. View at Publisher · View at Google Scholar